PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ:ARWR) today announced that Dr. Christopher Anzalone, Chief Executive Officer, will be presenting at the 9th Annual BIO Investor Forum at 4:30 p.m. PT on Tuesday, October 5, 2010, at the Palace Hotel in San Francisco, CA. Dr. Anzalone will be discussing the Company and its increased focus on its nanomedicine portfolio, including clinical results.
